The anticoagulant effect of hexolame (cas 110346-23-1), N-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-6-hydroxyhexylamine, another amino-estrogen with prolonged anticoagulant effect

Add time:08/11/2019    Source:sciencedirect.com

The anticoagulant and estrogenic effects of hexolame, N-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-6-hydroxyhexylamine, are described. A single subcutaneous injection of hexolame in adult and infant male mice produced dose-dependent increases in blood clotting time which could be observed even after 2 days. In ovariectomized mice, hexolame produced vaginal cornification (estrogenic response). The data suggested that if used in the treatment of prostatic cancer, hexolame, like prolame, would not induce cardiovascular accidents. It could also be useful in the prevention of thrombosis. (Steroids 55:83–86, 1990)

We also recommend Trading Suppliers and Manufacturers of hexolame (cas 110346-23-1). Pls Click Website Link as below: cas 110346-23-1 suppliers

Prev:Original ArticleA negative correlation of thyroid stimulating hormone with anti_mullerian hormone and with luteinizing hormone in polycystic ovary syndrome and/or hypothyroid women
Next:Role of the functional group in n-octydimethylsilanes in the synthesis of C8 reversed-phase silica packings for high-performance liquid chromatography)